Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib [0.03%]
白癜病：鲁索利替尼及其他鲁索利替尼之外的口服治疗选择
Hira Ghani,Isabella J Tan,Sasha Ghofrani et al.
Hira Ghani et al.
Background: Vitiligo is a chronic autoimmune disorder marked by the loss of melanocytes, causing depigmented patches across the skin. Affecting up to 2% of the global population, vitiligo presents significant psychologica...
Biophysical Characteristics of Lip Vermilion among Healthy Individuals in Southern China -- Correlations between Age and Vermilion Physiology [0.03%]
中国南方健康人群唇红组织的生物物理特性年龄因素与唇红生理属性的相关性研究
Yaru Wang,Qidi He,Fanqi Kong et al.
Yaru Wang et al.
Background: The vermilion of the lips plays an important role in the aesthetic appreciation of the lower face. However, there were few human subject studies on the vermilion of the lips in China. This study aimed to inves...